Combined low-level laser and ultrasound therapy showed possible efficacy and safety for growing pains in children over 30 days.
This pilot randomized controlled trial assessed the safety and efficacy of combined low-level laser and ultrasound therapy compared with a placebo group. The study population consisted of children aged four to twelve years diagnosed with growing pains. Participants were followed for 30 days to evaluate outcomes.
The primary results indicated clinical safety and possible efficacy for the combined therapy. No specific adverse events, serious adverse events, or discontinuations were reported in the provided data. The tolerability profile was described as indicating clinical safety.
Key limitations include the classification of the study as a pilot study. Consequently, the certainty regarding efficacy is described as possible rather than definitive. The findings reinforce the need for further clinical trials to confirm these results.
Practice relevance is limited by the pilot nature of the research. Clinicians should interpret these results with caution while awaiting larger, definitive trials.